Chiron Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,621
Closed -$594K 81
2023
Q2
$594K Sell
4,621
-2,507
-35% -$303K 0.17% 58
2023
Q1
$828K Buy
7,128
+5,725
+408% +$641K 0.15% 63
2022
Q4
$159K Sell
1,403
-697
-33% -$76.5K 0.04% 94
2022
Q3
$169K Buy
+2,100
New +$178K 0.03% 95
2022
Q1
Sell
-4,232
Closed -$568K 96
2021
Q4
$568K Buy
+4,232
New +$608K 0.06% 60

Other funds holding DXCM

Chiron Investment Management's DXCM Position: Q3 2023 in Review

Chiron Investment Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 4,621 shares — an estimated $594K sold.

Chiron Investment Management first reported a position in DXCM in Q4 2021 and held it in 5 quarters. The position peaked at $828K in Q1 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Chiron Investment Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Chiron Investment Management sold 4,621 DexCom shares in Q3 2023, an estimated $594K.
  • Chiron Investment Management first reported a position in DexCom in Q4 2021 and held it in 5 quarters.
  • Chiron Investment Management's DexCom position peaked at $828K in Q1 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Chiron Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.